Feasibility Performance Study of ABL90 FLEX PLUS HEM
Recruiting
Observational Study
Hemolysis
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 95 (estimated)
- Sponsor
- Radiometer Medical ApS · Industry
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This feasibility performance study evaluates the ABL90 FLEX PLUS HEM device for its analytical performance in a clinical setting. The study aims to evaluate the performance of the hemolysis detection feature.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Subject must be 18 years of age or older
* Informed consent is obtained:
* Directly from the subject, if they are competent and able to understand the provided information and voluntarily agree to participate, or
* If the subject is temporarily incapacitated and unable to…
Contacts